160 related articles for article (PubMed ID: 30539537)
1. Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy.
Sun CH; Berg K; Hirschberg H
Methods Mol Biol; 2019; 1895():165-176. PubMed ID: 30539537
[TBL] [Abstract][Full Text] [Related]
2. Enhanced gene transfection of macrophages by photochemical internalization: Potential for gene-directed enzyme prodrug therapy of gliomas.
Romena G; Nguyen L; Berg K; Madsen SJ; Hirschberg H
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102098. PubMed ID: 33188941
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy.
Christie C; Pomeroy A; Nair R; Berg K; Hirschberg H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():140-148. PubMed ID: 28257943
[TBL] [Abstract][Full Text] [Related]
4. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
[TBL] [Abstract][Full Text] [Related]
5. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
[TBL] [Abstract][Full Text] [Related]
6. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene.
Wang F; Zamora G; Sun CH; Trinidad A; Chun C; Kwon YJ; Berg K; Madsen SJ; Hirschberg H
J Neurooncol; 2014 May; 118(1):29-37. PubMed ID: 24610460
[TBL] [Abstract][Full Text] [Related]
8. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
9. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
[TBL] [Abstract][Full Text] [Related]
10. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
[TBL] [Abstract][Full Text] [Related]
11. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Pesta M; Pitule P; Topolcan O; Kausitz J; Zduriencikova M; Repiska V; Altaner C
Int J Cancer; 2019 Feb; 144(4):897-908. PubMed ID: 30098225
[TBL] [Abstract][Full Text] [Related]
12. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy-driven induction of suicide cytosine deaminase gene.
Bil J; Wlodarski P; Winiarska M; Kurzaj Z; Issat T; Jozkowicz A; Wegiel B; Dulak J; Golab J
Cancer Lett; 2010 Apr; 290(2):216-22. PubMed ID: 19822393
[TBL] [Abstract][Full Text] [Related]
14. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
[TBL] [Abstract][Full Text] [Related]
15. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy.
Barresi V; Belluardo N; Sipione S; Mudò G; Cattaneo E; Condorelli DF
Cancer Gene Ther; 2003 May; 10(5):396-402. PubMed ID: 12719709
[TBL] [Abstract][Full Text] [Related]
17. Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.
Torimura T; Ueno T; Taniguchi E; Masuda H; Iwamoto H; Nakamura T; Inoue K; Hashimoto O; Abe M; Koga H; Barresi V; Nakashima E; Yano H; Sata M
Cancer Sci; 2012 Mar; 103(3):542-8. PubMed ID: 22151662
[TBL] [Abstract][Full Text] [Related]
18. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.
Kim KY; Kim SU; Leung PC; Jeung EB; Choi KC
Cancer Sci; 2010 Apr; 101(4):955-62. PubMed ID: 20704576
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.
Johnson AJ; Ardiani A; Sanchez-Bonilla M; Black ME
Cancer Gene Ther; 2011 Aug; 18(8):533-42. PubMed ID: 21394105
[TBL] [Abstract][Full Text] [Related]
20. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.
Pederson LC; Vickers SM; Buchsbaum DJ; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
J Gastrointest Surg; 1998; 2(3):283-91. PubMed ID: 9841986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
